Celcuity secures FDA breakthrough therapy designation for breast cancer drug startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.
Stereotaxis, Inc. (NYSE:NYSE:STXS) Q1 2022 Earnings Conference Call May 10, 2022, 10:00 AM ET Company Participants David Fischel - Chairman and CEO Kim Peery - Chief Financial Officer.